# Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitation In Heart Failure (The EVOLVE-MR Trial)

> **NCT03891823** · NA · TERMINATED · sponsor: **Montreal Heart Institute** · enrollment: 9 (actual)

## Conditions studied

- Ventricular Remodeling, Left

## Interventions

- **DEVICE:** MitraClip
- **DRUG:** Medical Therapy

## Key facts

- **NCT ID:** NCT03891823
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-08
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-05-15
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Lack of recruitment.
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891823, "Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitation In Heart Failure (The EVOLVE-MR Trial)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03891823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*